Newpeak Metals Limited

NPM

NewPeak Metals Ltd. engages in coal and lithium exploration in Argentina, oil and gas in Australia, and gold exploration in U.S. Its projects include cachi gold, san Jorge lithium brine and las openas gold. The company is headquartered in Brisbane, Queensland. The company went IPO on 2011-04-11. The firm is focused on discovering a multimillion-ounce gold deposit. The firm is engaged in holding strategic positions in several gold properties in jurisdictions, including Finland, New Zealand, and Argentina, together with Tungsten projects in Sweden. Its suite of Southern Finland projects lies in a region, which hosts three gold mines (Orivesi, Jokisivu and Kaapelinkulma) with a processing facility at Vammala. The firm holds interest in Cachi Gold Project and Las Openas Gold Project in Argentina. The Cachi Gold Project is an approximately 46,892 hectares (ha) lease package located in the central-western region of Santa Cruz Province, Argentina. The Las Openas Gold Project is located in the mining province of San Juan. The company also has an interest in Cap Burn Gold Project, in Otago, New Zealand and the Santana-Matakanui Bendigo-Ophir project in the west. The company has the Sweden Strategic Metals Project in Sweden.

Novatti Group Limited

NOV

Novatti Group Ltd. provides software technology and systems integration services. The company is headquartered in Melbourne, Victoria. The company went IPO on 2016-01-18. The Company’s Technology segment develops, deploys, and supports specialized mobile and alternate payment technology, primarily through the deployment of the Novatti Platform. The Business Automation segment automates business processes, including customer engagement, billing, collections, and others. The Alternative Payments segment offers customers an alternative payment method in the form of a prepaid cash voucher. The Banking Services segment offers new banking services to Australian customers with a focus on the migrant demographic. The Issuing segment provides a payment system centered around reloadable prepaid cards that meet the needs and wants of international and local university and college students. ATX payments segment provides a large, established payments network across Malaysia. Acquiring segment enables businesses to accept payments online for e-commerce.

Noxopharm Limited

NOX

Noxopharm Ltd. engages in the research and development of drugs. The company is headquartered in Gordon, New South Wales. The company went IPO on 2016-08-09. The firm is engaged in the discovery and development of treatments for cancer and inflammation. The firm has three active drug development programs: its clinical drug candidate Veyonda, plus two technology platforms, Chroma (oncology) and Sofra (inflammation and autoimmunity), which provide the basis for the active development of a growing pipeline of drugs. Veyonda (Idronoxil) is an adjuvant therapy in chemotherapy and radiotherapy in the treatment of late-stage cancers. The Chroma drug candidates have bioactive properties, which it is exploring primarily in the anti-cancer space. Its Sofra platform is centered around short nucleic acid sequences called oligonucleotides, which can act on specific cell receptors to stop inflammation, which is a source of various debilitating and lethal diseases. The company is also conducting a dose escalation and dose expansion study of NOX66 in the treatment of COVID-19 infection.